查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088646

犬異位性皮膚炎市場：2026-2032年全球市場預測（依產品類型、給藥途徑、適應症、年齡層和分銷管道分類）

Canine Atopic Dermatitis Market by Product Type, Route of Administration, Indication, Age Group, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，犬類異位性皮膚炎市場規模將達到 70 億美元，複合年成長率為 6.31%。

主要市場統計數據
基準年 2025 45.6億美元
預計年份：2026年 48.3億美元
預測年份 2032 70億美元
複合年成長率 (%) 6.31%

犬特發性皮膚炎市場概覽

犬異位性皮膚炎是一種慢性、復發性發炎性搔癢性皮膚病，與遺傳易感性、皮膚屏障功能受損、環境過敏原、微生物群失調和免疫訊號傳導有關。在獸醫皮膚病學領域，它被廣泛認為是導致犬隻持續搔癢、復發性外耳炎、舔爪、繼發性細菌或酵母菌病菌感染、睡眠障礙以及生活品質下降的最常見原因之一。

犬特異性皮膚炎領域的變革性變化

犬類皮膚炎的治療模式正從暫時緩解搔癢轉向預防和多方面綜合管理。獸醫們擴大將針對性的止癢療法、合理使用抗生素、修復皮膚屏障功能、避免接觸過敏原、營養支持、寄生蟲控制以及飼主教育相結合，以控制症狀加重，同時降低復發和繼發感染的風險。

人工智慧在獸醫皮膚病學中的累積影響

人工智慧不再是遙遠的概念，它正在成為獸醫皮膚病學中的實用工具。影像分析有助於對皮膚病變進行分診，數位化問卷工具可以系統化地記錄飼主報告的搔癢評分，而預測分析則可以根據季節性、用藥史、病變進展和並發感染疾病，幫助識別症狀復發風險較高的犬隻。

犬特異性皮膚炎的關鍵區域性見解

北美在犬類特異性皮膚炎的治療方面仍然高度發達，這得益於其在寵物醫療保健方面的高額投入、獸醫專家的廣泛普及、寵物保險的普及以及處方箋止癢藥物的積極應用。歐洲也展現出類似的成熟度，這得益於其完善的獸醫皮膚病學網路、受監管的動物用藥品獲取管道、高標準的藥物安全監測以及對在慢性皮膚病治療中合理使用抗菌藥物的高度重視。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

在東協地區，都市區寵物飼養量的增加、人們對慢性搔癢性皮膚病認知的提高以及小型動物診所就診管道的改善，推動了新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國對犬類特異性皮膚炎治療的需求。海灣合作理事會地區（GCC）的特點是，阿拉伯聯合大公國、沙烏地阿拉伯、卡達、科威特、巴林和阿曼等國對高階獸醫服務的需求日益成長，進口治療藥物、皮膚病學服務和伴侶動物健康服務在主要城市市場中變得越來越重要。

重點國家對犬類特異性皮膚炎治療需求的洞察。

美國的需求成長主要得益於其在寵物身上的高支出、先進療法的廣泛應用、全科醫療服務的普及以及專科獸醫皮膚科醫生的廣泛就診。加拿大緊隨其後，這得益於其高標準的獸醫護理、寵物保險的日益普及以及對慢性過敏性皮膚病的高度重視。同時，墨西哥的需求也在成長，這得益於都市區動物醫院的現代化以及寵物藥品供應的不斷擴大。巴西是拉丁美洲的主要成長引擎，這得益於其龐大的寵物數量、活躍的獸藥行業以及飼主對治療復發性瘙癢和外耳炎日益成長的需求。

為行業領導者提供的實用建議

產業領導者應投資於能夠全面解決犬類特異性皮膚炎問題的治療和支持項目，涵蓋從診斷和症狀管理到長期維持的各個方面。商業性成功取決於能否證明其能夠快速緩解搔癢、持續安全、與多方面護理相容、減少對反覆使用皮質類固醇的依賴，以及顯著改善飼主的生活品質。

調查方法

本執行摘要是基於獸醫皮膚病學實踐模式、法規環境、治療創新、伴侶動物健康趨勢和區域需求趨勢的系統評估。分析重點關注來自權威獸醫臨床指南、已批准的治療類別、同行評審的皮膚病學文獻、藥物安全監測原則以及寵物醫療保健服務中可觀察到的變化的證據。

結論

犬類特異性皮膚炎市場正朝著個人化、長期疾病管理的方向發展，這得益於標靶治療、生物製藥、診斷、營養管理、外用藥物、過敏原特異性免疫療法以及數位互動等手段的運用。能夠幫助獸醫透過持續的治療效果和可操作的工作流程來管理慢性及復發性疾病的機構，將擁有最大的商機。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：犬異位性皮膚炎市場：依產品類型分類

  • 營養保健品
    • ω-3脂肪酸
    • Omega-6脂肪酸
    • 益生菌
  • 糖皮質激素
    • 強的松
    • 潑尼松龍
    • 地塞米松
  • 免疫抑制劑
    • Cyclosporine
    • Tacrolimus
    • Azathioprine
  • 抗組織胺藥
    • 苯海拉明
    • 撲爾敏
    • 羥嗪
  • 單株抗體（MAbs）
  • 局部治療
    • 皮質類固醇乳膏
    • 抗菌洗髮精

第8章：犬異位性皮膚炎市場：依給藥途徑分類

  • 口服
  • 注射藥物

第9章：犬異位性皮膚炎市場：依適應症分類

  • 環境過敏原
    • 花粉
    • 塵蟎
  • 食物過敏
  • 跳蚤過敏性皮膚炎
  • 季節性過敏

第10章：犬異位性皮膚炎市場：依年齡層別分類

  • 小狗
  • 成犬
  • 老年犬

第11章：犬異位性皮膚炎市場：依分銷管道分類

  • 線上
  • 離線
    • 獸醫醫院和診所
    • 寵物專賣店

第12章：犬異位性皮膚炎市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：犬異位性皮膚炎市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：犬異位性皮膚炎市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • AB Science SA
  • AbbVie, Inc.
  • Agrolabo SpA
  • Bimeda, Inc.
  • Bioceltix JSC
  • Bioiberica SAU
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Farnam Companies, Inc.
  • IDEXX Laboratories, Inc.
  • Incyte Corporation
  • Kemin Industries, Inc.
  • LEO Pharma A/S
  • Merck & Co. Inc.
  • Natural Dog Company
  • Nextmune
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Novartis AG
  • Ourofino Animal Health
  • Pet King Brands LLC
  • Phibro Animal Health Corporation
  • Regeneron Pharmaceuticals, Inc
  • Vetoquinol SA
  • Virbac Corporation
  • Zoetis Inc.
Product Code: MRR-A339DAEFA20E

The Canine Atopic Dermatitis Market is projected to grow by USD 7.00 billion at a CAGR of 6.31% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.56 billion
Estimated Year [2026] USD 4.83 billion
Forecast Year [2032] USD 7.00 billion
CAGR (%) 6.31%

Canine Atopic Dermatitis Market Introduction

Canine atopic dermatitis is a chronic, relapsing inflammatory and pruritic skin disease associated with genetic predisposition, impaired skin-barrier function, environmental allergens, microbial dysbiosis, and immune signaling. It is widely recognized in veterinary dermatology as one of the most common causes of persistent itching, recurrent otitis externa, paw licking, secondary bacterial or yeast infections, sleep disturbance, and reduced quality of life in dogs.

The canine atopic dermatitis market is advancing as pet owners increasingly treat dogs as family members and expect evidence-based, long-term dermatology care. Demand is strongest for solutions that reduce pruritus quickly, limit prolonged corticosteroid exposure, support year-round disease control, and integrate easily into routine veterinary workflows. This creates opportunities across prescription antipruritic therapies, biologics, Janus kinase inhibitors, immunomodulators, allergen-specific immunotherapy, medicated topicals, dermatology diagnostics, therapeutic nutrition, and digital monitoring tools.

Transformative Shifts in the Canine Atopic Dermatitis Landscape

The competitive landscape is shifting from episodic itch relief toward proactive, multimodal management of canine atopic dermatitis. Veterinarians increasingly combine targeted antipruritic therapy, antimicrobial stewardship, skin-barrier repair, allergen avoidance, nutritional support, parasite control, and client education to manage flares while reducing recurrence and secondary infection risk.

Innovation is also moving treatment decisions closer to the individual dog. Breed predisposition, age of onset, seasonality, lesion distribution, concurrent otitis, food allergy evaluation, ectoparasite exclusion, infection status, and prior treatment response are now central to therapy selection. Suppliers that support veterinarians with clear clinical pathways, adherence tools, practical dosing options, and robust safety evidence are better positioned than those competing on product availability alone.

Cumulative Impact of Artificial Intelligence on Veterinary Dermatology

Artificial intelligence is becoming a practical enabler in veterinary dermatology rather than a distant concept. Image analysis can support triage of skin lesions, digital intake tools can structure owner-reported itch scores, and predictive analytics can help identify dogs at higher risk of flare recurrence based on seasonality, medication history, lesion progression, and comorbid infections.

The cumulative impact of AI is strongest when it improves workflow efficiency and treatment continuity. Veterinary teams can use AI-assisted reminders, teledermatology documentation, inventory planning, clinical note structuring, and outcomes tracking to improve adherence and detect relapse earlier. However, clinical oversight remains essential because canine atopic dermatitis is a diagnosis of exclusion and requires assessment for parasites, infection, food allergy, contact reactions, and other pruritic diseases before long-term therapy is selected.

Key Regional Insights for Canine Atopic Dermatitis

North America remains a highly developed region for canine atopic dermatitis treatment due to advanced companion animal healthcare spending, broad access to veterinary specialists, pet insurance adoption, and strong use of prescription antipruritic therapies. Europe shows similar maturity, supported by established veterinary dermatology networks, regulated access to veterinary medicines, high standards for pharmacovigilance, and strong emphasis on antimicrobial stewardship in chronic skin disease management.

Asia-Pacific is gaining momentum as urban pet ownership, veterinary clinic expansion, premium pet care spending, and awareness of chronic allergic skin disease rise across China, Japan, South Korea, India, Australia, and Southeast Asia. Latin America, led by Brazil and Mexico, is benefiting from a growing companion animal base, expanding small animal practice capabilities, and increasing availability of modern dermatology products. The Middle East is developing through premium veterinary services in urban centers, particularly where imported medicines and specialist referral care are more accessible, while Africa remains more uneven, with activity concentrated in private clinics serving major cities and higher-income pet owners.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, canine atopic dermatitis demand is supported by expanding urban pet ownership, rising awareness of chronic pruritic skin disease, and improving access to small animal clinics in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is characterized by premium veterinary care demand across the United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Bahrain, and Oman, where imported therapies, dermatology consultations, and companion animal wellness services are increasingly visible in major urban markets.

The European Union offers a structured regulatory and clinical environment that rewards safety, pharmacovigilance, antimicrobial stewardship, and evidence-based prescribing. BRICS markets combine large dog populations with variable access to advanced therapies, creating opportunities for veterinary education, diagnostic support, and tiered product strategies. G7 countries represent highly sophisticated demand environments with advanced clinic infrastructure and stronger willingness to pay for chronic pet care, while NATO membership overlaps with many high-income markets where veterinary capacity, medicine access, and pet insurance penetration support consistent dermatology care.

Key Country Insights for Canine Atopic Dermatitis Demand

The United States leads demand through high companion animal expenditure, broad adoption of advanced therapeutics, extensive general practice coverage, and access to specialty veterinary dermatologists. Canada follows with strong veterinary standards, growing pet insurance use, and high awareness of chronic allergic skin disease, while Mexico is advancing through urban clinic modernization and wider availability of companion animal medicines. Brazil is Latin America's key growth engine because of its large pet population, active veterinary pharmaceutical sector, and increasing owner willingness to seek treatment for recurrent pruritus and otitis.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show strong demand for evidence-based dermatology protocols, responsible antimicrobial use, and long-term maintenance options for canine atopic dermatitis, while Russia presents a more complex access environment influenced by distribution, regulatory, and macroeconomic factors. China and India offer substantial long-term potential as pet ownership, middle-class spending, and clinic capacity expand, although access to specialty dermatology remains uneven. Japan, Australia, and South Korea are mature Asia-Pacific markets where premium pet care, preventive medicine, high clinical standards, and specialist referral networks support adoption of advanced canine atopic dermatitis solutions.

Actionable Recommendations for Industry Leaders

Industry leaders should invest in therapies and support programs that address the full canine atopic dermatitis journey, from diagnosis and flare control to long-term maintenance. Commercial success will depend on demonstrating rapid itch reduction, sustained safety, compatibility with multimodal care, reduced reliance on repeated corticosteroid use, and measurable improvement in owner-perceived quality of life.

Organizations should strengthen veterinary education, digital adherence programs, real-world evidence generation, and region-specific access models. Partnerships with dermatology specialists, diagnostic laboratories, telehealth platforms, continuing education providers, and pet insurance stakeholders can improve treatment continuity and differentiate solutions in an increasingly outcomes-driven companion animal dermatology market.

Research Methodology

This executive summary is based on a structured assessment of veterinary dermatology practice patterns, regulatory context, therapeutic innovation, companion animal health trends, and regional demand dynamics. The analysis prioritizes evidence from recognized veterinary clinical guidance, approved therapeutic categories, peer-reviewed dermatology literature, pharmacovigilance principles, and observable shifts in pet healthcare delivery.

The methodology evaluates demand drivers, treatment pathways, adoption barriers, competitive positioning, access conditions, and geographic growth signals without applying market estimation, market sizing, market share, or forecasting. Insights were triangulated across clinical, commercial, regulatory, and operational factors to produce the view of the canine atopic dermatitis market.

Conclusion

The canine atopic dermatitis market is moving toward personalized, long-term disease control supported by targeted drugs, biologics, diagnostics, nutrition, medicated topicals, allergen-specific immunotherapy, and digital engagement. The strongest opportunities will favor organizations that help veterinarians manage a chronic, relapsing condition with consistent outcomes and practical workflows.

As pet owners demand safer, faster, and more convenient dermatology care, industry leaders must combine scientific credibility with access planning, veterinary education, and client adherence strategies. Organizations that align innovation with real-world veterinary practice will be best positioned to support sustainable growth in canine atopic dermatitis care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Canine Atopic Dermatitis Market, by Product Type

  • 7.1. Nutraceuticals
    • 7.1.1. Omega-3 fatty Acids
    • 7.1.2. Omega-6 fatty Acids
    • 7.1.3. Probiotics
  • 7.2. Glucocorticoids
    • 7.2.1. Prednisone
    • 7.2.2. Prednisolone
    • 7.2.3. Dexamethasone
  • 7.3. Immunosuppressants
    • 7.3.1. Cyclosporine
    • 7.3.2. Tacrolimus
    • 7.3.3. Azathioprine
  • 7.4. Antihistamines
    • 7.4.1. Diphenhydramine
    • 7.4.2. Chlorpheniramine
    • 7.4.3. Hydroxyzine
  • 7.5. Monoclonal Antibodies (MAbs)
  • 7.6. Topical Therapies
    • 7.6.1. Corticosteroid Creams
    • 7.6.2. Antibacterial Shampoos

8. Canine Atopic Dermatitis Market, by Route of Administration

  • 8.1. Oral
  • 8.2. Injectable

9. Canine Atopic Dermatitis Market, by Indication

  • 9.1. Environmental Allergens
    • 9.1.1. Pollen
    • 9.1.2. Dust Mites
  • 9.2. Food Allergies
  • 9.3. Flea Allergy Dermatitis
  • 9.4. Seasonal Allergies

10. Canine Atopic Dermatitis Market, by Age Group

  • 10.1. Puppies
  • 10.2. Adult Dogs
  • 10.3. Senior Dogs

11. Canine Atopic Dermatitis Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Offline
    • 11.2.1. Veterinary Hospitals & Clinics
    • 11.2.2. Pet Specialty Stores

12. Canine Atopic Dermatitis Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Canine Atopic Dermatitis Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Canine Atopic Dermatitis Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. AB Science SA
  • 16.2. AbbVie, Inc.
  • 16.3. Agrolabo SpA
  • 16.4. Bimeda, Inc.
  • 16.5. Bioceltix JSC
  • 16.6. Bioiberica S.A.U.
  • 16.7. Boehringer Ingelheim International GmbH
  • 16.8. Ceva Sante Animale
  • 16.9. Dechra Pharmaceuticals PLC
  • 16.10. Elanco Animal Health Incorporated
  • 16.11. Farnam Companies, Inc.
  • 16.12. IDEXX Laboratories, Inc.
  • 16.13. Incyte Corporation
  • 16.14. Kemin Industries, Inc.
  • 16.15. LEO Pharma A/S
  • 16.16. Merck & Co. Inc.
  • 16.17. Natural Dog Company
  • 16.18. Nextmune
  • 16.19. Nippon Zenyaku Kogyo Co., Ltd.
  • 16.20. Novartis AG
  • 16.21. Ourofino Animal Health
  • 16.22. Pet King Brands LLC
  • 16.23. Phibro Animal Health Corporation
  • 16.24. Regeneron Pharmaceuticals, Inc
  • 16.25. Vetoquinol S.A.
  • 16.26. Virbac Corporation
  • 16.27. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CANINE ATOPIC DERMATITIS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CANINE ATOPIC DERMATITIS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CANINE ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NUTRACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL OMEGA-3 FATTY ACIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL OMEGA-3 FATTY ACIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL OMEGA-3 FATTY ACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OMEGA-6 FATTY ACIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OMEGA-6 FATTY ACIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OMEGA-6 FATTY ACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PROBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PROBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GLUCOCORTICOIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GLUCOCORTICOIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GLUCOCORTICOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PREDNISONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PREDNISONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PREDNISONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PREDNISOLONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PREDNISOLONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PREDNISOLONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DEXAMETHASONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DEXAMETHASONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DEXAMETHASONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMMUNOSUPPRESSANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IMMUNOSUPPRESSANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMMUNOSUPPRESSANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CYCLOSPORINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CYCLOSPORINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CYCLOSPORINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TACROLIMUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TACROLIMUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TACROLIMUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AZATHIOPRINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AZATHIOPRINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AZATHIOPRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTIHISTAMINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANTIHISTAMINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTIHISTAMINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIPHENHYDRAMINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIPHENHYDRAMINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIPHENHYDRAMINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CHLORPHENIRAMINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CHLORPHENIRAMINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CHLORPHENIRAMINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HYDROXYZINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HYDROXYZINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HYDROXYZINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MONOCLONAL ANTIBODIES (MABS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MONOCLONAL ANTIBODIES (MABS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MONOCLONAL ANTIBODIES (MABS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TOPICAL THERAPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TOPICAL THERAPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TOPICAL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORTICOSTEROID CREAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CORTICOSTEROID CREAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORTICOSTEROID CREAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANTIBACTERIAL SHAMPOOS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTIBACTERIAL SHAMPOOS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANTIBACTERIAL SHAMPOOS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENVIRONMENTAL ALLERGENS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENVIRONMENTAL ALLERGENS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENVIRONMENTAL ALLERGENS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL POLLEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL POLLEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL POLLEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DUST MITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DUST MITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DUST MITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FOOD ALLERGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FOOD ALLERGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FOOD ALLERGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FLEA ALLERGY DERMATITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FLEA ALLERGY DERMATITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FLEA ALLERGY DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SEASONAL ALLERGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SEASONAL ALLERGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SEASONAL ALLERGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PUPPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PUPPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PUPPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ADULT DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ADULT DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ADULT DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SENIOR DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SENIOR DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SENIOR DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PET SPECIALTY STORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PET SPECIALTY STORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PET SPECIALTY STORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 211. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 212. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 213. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 214. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 247. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 249. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 250. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 251. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 252. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 253. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 254. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 262. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 263. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 264. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 265. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 266. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 267. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 268. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 287. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 289. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 293. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 294. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 295. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 296. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 300. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 301. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 302. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 303. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 304. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 305. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 306. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 307. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 308. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 309. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 313. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 314. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 315. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 317. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 318. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 319. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 320. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 321. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 336. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 337. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 339. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2018-2032 (USD MILLION)
  • TABLE 340. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
  • TABLE 341. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2018-2032 (USD MILLION)
  • TABLE 342. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 343. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 344. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 345. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2018-2032 (USD MILLION)
  • TABLE 346. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 347. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (U